Coronavirus infection sars-cov-2(covid-19) in patients with type 2 diabetes mellitus and the effect of glucose-lowering therapy on disease outcomes
Underlying diabetes mellitus type 2 are considered risk factor for increased coronavirus disease (COVID-19) disease severity and worse outcomes, including higher mortality, respiratory failure, thromboembolic complications.In this regard, it is relevant to study the factors influencing the unfavorable outcomes of the course of Covid-19 in diabetes mellitus type 2. The most important task is to organize the management of diabetes mellitus during the period of coronavirus infection and the choice of safe and effective glucose-lowering therapy. This article analyzes the impact of previous and current glucose-lowering therapy on the outcomes of coronavirus infection in patients with diabetes mellitus type 2 based on published research results
Сведения
- Журнал
- Astana Medical Journal
- Опубликовано
- 2022 · С. 37-45
- Язык
- Английский
- ISSN
- 1562-2940 · 2790-1203
- Издатель
- NpJSC "Astana Medical University